Innovative pharma companies are under tremendous pressure to reduce drug prices as they face administrative demands for better quality of care and lower costs. Key decisions around the conduct of clinical trials, especially their locations, can have a positive impact on reducing the overall cost of bringing the drug to market.
Multiple strategic factors determine the optimal location for conducting trials, such as the location of key partners, healthcare infrastructure, future launches, patient population, and regulatory policies. IQVIA recently studied the countries of Middle East, Turkey, and Africa (META) region – their healthcare infrastructure, regulations, patient pools, and other attributes. Download and read our report for an overview of the current clinical trial landscape in this potentially strategic location.